Latest Commercialisation News

Biotron Limited has launched a $1.5 million non-renounceable rights issue to fund its strategic acquisition of Sedarex Limited and support ongoing drug development programs. The capital raise follows shareholder approval and aims to diversify Biotron’s portfolio with a next-generation general anaesthetic.

Vintage Energy has signed a conditional agreement to acquire Metgasco's 25% interest in key Southern Flank gas joint ventures, aiming to accelerate production and value creation from the Vali and Odin fields.

Clover Corporation Limited reported a standout FY25 with robust revenue growth and a sharp rise in profitability, underpinned by strategic market expansion and product innovation. The company’s strengthened balance sheet and optimistic FY26 outlook signal continued momentum.

Zeotech Limited has signed a non-binding Letter of Intent with Bisley & Company to explore marketing and distribution of its high-reactivity metakaolin product, AusPozz™, across Australia and key international markets.

Harvest Technology Group has forged a pivotal exclusive reseller agreement with Pyxis Controls to expand its Nodestream™ technology across the MENATISA region, targeting critical sectors like national security and energy.

Critical Resources Limited has secured a 12-month exclusive option to evaluate advanced solid-state lithium-ion battery technology from the South Dakota School of Mines & Technology, aiming to enhance battery safety, performance, and commercial potential.

Metallium Ltd has secured exclusive rights to apply its breakthrough Flash Joule Heating technology to the heavy rare earth-rich Harts Range Project, achieving an unprecedented 20-fold upgrade in rare earth concentration. This deal positions Metallium as a key player in Western critical minerals supply amid global geopolitical tensions.

New Frontier Minerals has locked in a decade-long exclusive agreement with Metallium to apply cutting-edge Flash Joule Heating technology to its Harts Range ore, achieving unprecedented rare earth enrichment. This partnership targets strategic US defense and magnet markets, marking a pivotal step for the project’s commercial future.

Paradigm Biopharmaceuticals has drawn down US$5 million under its convertible note facility to fund the accelerated expansion of its global Phase 3 trial for knee osteoarthritis treatment.

Cobre Limited has landed a $4 million strategic investment from Tribeca Investment Partners to accelerate development of its Ngami In-Situ Copper Recovery project in Botswana, marking a key step toward commercialising this promising copper resource.

Livium Ltd has locked in exclusive worldwide rights to a cutting-edge microwave technology from the University of Melbourne, promising high recovery rates and energy savings in rare earth and platinum group metals extraction.

Algorae Pharmaceuticals has launched a Loyalty Options Offer, allowing eligible shareholders to purchase options at a nominal price, aiming to reward loyalty and support future growth funding.